Dopamine in Parkinson’s Disease and Schizophrenia

Prof. Shen-Yang Lim, MBBS MD FRACP FASc

Neurologist and Professor at the University of Malaya, Kuala Lumpur, Malaysia

Prof. Christoph U Correll, MD.

The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA. Charité – Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.

In this video, Professors Shen-Yang Lim and Christoph Correll discuss the crucial role of dopamine in both Parkinson’s disease and Schizophrenia.

Learn how dopamine deficiency leads to motor symptoms in Parkinson’s disease and how excessive dopaminergic activity contributes to psychosis in Schizophrenia. The discussion covers the evolution of treatments, including levodopa for Parkinson’s disease, and postsynaptic dopamine blockers for Schizophrenia. The conversation also touches on side effects, and parallels between these two brain disorders.